r 59022 has been researched along with n-methylscopolamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
el-Fakahany, EE; Lai, WS | 1 |
Dickinson, KE; Hirschowitz, BI; Hokin, LE; Pruitt, RE; Sekar, MC | 1 |
2 other study(ies) available for r 59022 and n-methylscopolamine
Article | Year |
---|---|
Antagonism by the diacylglycerol kinase inhibitor R59 022 of muscarinic receptor-mediated cyclic GMP formation and binding of [3H]N-methylscopolamine.
Topics: Animals; Binding, Competitive; Carbachol; Cyclic GMP; Diacylglycerol Kinase; Mice; Muscarinic Antagonists; N-Methylscopolamine; Phosphotransferases; Pyrimidinones; Receptors, Muscarinic; Scopolamine Derivatives; Thiazoles; Tumor Cells, Cultured | 1990 |
Muscarinic receptor antagonist activity of diacylglycerol lipase and kinase inhibitors.
Topics: Animals; Brain; Cells, Cultured; Cyclic GMP; Cyclohexanes; Cyclohexanones; Guinea Pigs; Heart; Lipoprotein Lipase; Myocardium; N-Methylscopolamine; Pancreas; Parasympatholytics; Platelet Activating Factor; Pyrimidinones; Rats; Receptors, Muscarinic; Scopolamine Derivatives; Thiazoles; Tritium | 1990 |